Table 5 Multivariate COX regression of independent prognostic factors of MpBC-TNBC and IDC-TNBC.
From: Chemotherapy is of prognostic significance to metaplastic breast cancer
| Â | BCSS | OS | ||||||
|---|---|---|---|---|---|---|---|---|
Univariate regression | Multivariate regression | Univariate regression | Multivariate regression | |||||
HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |
Histology | ||||||||
 IDC-TNBC | Ref. |  | Ref. |  | Ref. |  | Ref. |  |
 MpBC-TNBC | 1.227 (1.036–1.453) | 0.018 | 1.239 (1.046–1.468) | 0.013 | 1.245 (1.077–1.440) | 0.003 | 1.277 (1.104–1.477) | 0.001 |
Year of diagnosis | 1.030 (0.999–1.063) | 0.058 |  |  | 1.029 (1.002–1.057) | 0.037 | 1.045 (1.017–1.075) | 0.001 |
Age | ||||||||
  > 60y | Ref. |  |  |  | Ref. |  |  |  |
  ≤ 60y | 0.970 (0.842–1.118) | 0.678 |  |  | 0.840 (0.743–0.951) | 0.006 | 0.914 (0.800–1.044) | 0.183 |
Race | Â | 0.388 | Â | Â | Â | 0.124 | Â | Â |
 White | Ref. |  |  |  | Ref. |  |  |  |
 Black | 1.125 (0.931–1.359) | 0.223 |  |  | 1.124 (0.955–1.322) | 0.160 |  |  |
 Others* | 0.926 (0.684–1.253) | 0.618 |  |  | 0.832 (0.633–1.093) | 0.185 |  |  |
Stage |  |  < 0.001 |  |  < 0.001 |  |  < 0.001 |  |  < 0.001 |
 IIIC | Ref. |  | Ref. |  | Ref. |  | Ref. |  |
 I | 0.086 (0.055–0.136) |  < 0.001 | 0.102 (0.064–0.163) |  < 0.001 | 0.119 (0.080–0.176) |  < 0.001 | 0.131 (0.087–0.195) |  < 0.001 |
 IIA | 0.188 (0.124–0.286) |  < 0.001 | 0.217 (0.142–0.332) |  < 0.001 | 0.212 (0.146–0.307) |  < 0.001 | 0.228 (0.156–0.333) |  < 0.001 |
 IIB | 0.422 (0.277–0.643) |  < 0.001 | 0.458 (0.299–0.702) |  < 0.001 | 0.405 (0.278–0.592) |  < 0.001 | 0.431 (0.294–0.631) |  < 0.001 |
 IIIA | 0.507 (0.316–0.815) | 0.005 | 0.553 (0.342–0.894) | 0.016 | 0.477 (0.311–0.732) | 0.001 | 0.510 (0.331–0.788) | 0.002 |
 IIIB | 0.902 (0.580–1.403) | 0.648 | 0.885 (0.568–1.380) | 0.590 | 0.797 (0.534–1.190) | 0.267 | 0.767 (0.512–1.147) | 0.196 |
Surgery | ||||||||
 BCS | Ref. |  | Ref. |  | Ref. |  | Ref. |  |
 Mastectomy | 2.094 (1.801–2.434) |  < 0.001 | 1.333 (1.136–1.564) |  < 0.001 | 1.815 (1.599–2.060) |  < 0.001 | 1.268 (1.108–1.451) | 0.001 |
Radiation therapy | ||||||||
 No or unknown | Ref. |  |  |  | Ref. |  |  |  |
 Yes | 0.979 (0.851–1.127) | 0.772 |  |  | 0.895 (0.793–1.010) | 0.073 |  |  |
Chemotherapy |  |  < 0.001 |  |  < 0.001 |  |  < 0.001 |  |  < 0.001 |
 No CT | Ref. |  | Ref. |  | Ref. |  | Ref. |  |
 NAC- non response | 1.799 (1.277–2.535) | 0.001 | 0.801 (0.564–1.139) | 0.217 | 1.400 (1.015–1.931) | 0.040 | 0.683 (0.488–0.956) | 0.026 |
 NAC- response | 1.336 (1.070–1.668) | 0.011 | 0.841 (0.668–1.059) | 0.141 | 1.120 (0.918–1.365) | 0.264 | 0.759 (0.611–0.942) | 0.012 |
 Adjuvant CT | 0.686 (0.587–0.803) |  < 0.001 | 0.702 (0.598–0.823) |  < 0.001 | 0.634 (0.556–0.725) |  < 0.001 | 0.656 (0.570–0.755) |  < 0.001 |